Kenneth C. Rupert

Imidazopyrimidines, potent inhibitors of p38 MAP kinase

Kenneth C. Rupert, James R. Henry, John H. Dodd et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 249 citations · Full text

Medicinal Chemistry, P38 Map Kinase, Medicine +5

6-Amino-2-(4-fluorophenyl)-4-methoxy-3- (4-pyridyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (RWJ 68354):  A Potent and Selective p38 Kinase Inhibitor

James R. Henry, Kenneth C. Rupert, John H. Dodd et al. · Journal of Medicinal Chemistry · 1998 · 77 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Chemical Biology +20

In Vivo Characterization of a Dual Adenosine A_2A/A₁ Receptor Antagonist in Animal Models of Parkinson’s Disease

Brian C. Shook, Stefanie Rassnick, Melville C. Osborne et al. · Journal of Medicinal Chemistry · 2010 · 54 citations · Full text

Dual Adenosine A, Receptor Antagonist, Pharmacotherapy +19

Potent inhibitors of the MAP kinase p38

James R. Henry, Kenneth C. Rupert, John H. Dodd et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 43 citations · Full text

Medicinal Chemistry, Medicine, Receptor Tyrosine Kinase +8

Optimization of Benzodiazepinones as Selective Inhibitors of the X-Linked Inhibitor of Apoptosis Protein (XIAP) Second Baculovirus IAP Repeat (BIR2) Domain

Robert F. Kester, Andrew F. Donnell, Yan Lou et al. · Journal of Medicinal Chemistry · 2013 · 38 citations · Full text

X-linked Inhibitor, Xiap Bir3, Drug Target +14